Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis c | D006526 | — | B19.2 | — | 1 | — | — | 1 | 2 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | 1 | — | — | 1 | 2 |
Hepatitis | D006505 | HP_0012115 | K75.9 | — | 1 | — | — | 1 | 2 |
Chronic hepatitis | D006521 | — | K73.9 | — | 1 | — | — | 1 | 2 |
Head and neck neoplasms | D006258 | — | — | — | 2 | — | — | — | 2 |
Stomatitis | D013280 | EFO_1001904 | K12.1 | — | 2 | — | — | — | 2 |
Mucositis | D052016 | EFO_1001898 | — | — | 2 | — | — | — | 2 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | 1 | — | — | — | 1 |
Drug common name | GOLOTIMOD |
INN | golotimod |
Description | Golotimod is a dipeptide. |
Classification | Small molecule |
Drug class | immunomodulators |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O |
PDB | — |
CAS-ID | 229305-39-9 |
RxCUI | — |
ChEMBL ID | CHEMBL2103812 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB05475 |
UNII ID | 637C487Y09 (ChemIDplus, GSRS) |